Ask someone what Edmonton is known for and they’ll likely mention the energy sector, the Oilers, the city’s reputation for having what was once the world’s largest mall or currently the world’s largest fringe festival and many other events which has led to its moniker as Canada’s Festival City. But Edmonton has another identity that’s rapidly gaining global recognition: it is at the core of a rapidly growing Life Sciences sector in Alberta.
Alberta’s Life Sciences sector has grown from $894 million in GDP in 2018 to over $4.7 billion in 2024. Edmonton is home to the country’s largest consortium of virologists and a growing network of researchers and scale-ups leading advancements in advanced therapies, digital health and biomanufacturing. As this ecosystem has continued to grow, conditions have become ideal for a much-needed Life Sciences Campus – and that’s exactly what we’re building.
The Life Sciences Corridor
Surrounded by world-class institutions like the Alberta Diabetes Institute, the Li Ka Shing Institute of Virology and the Cross Cancer Institute, the Life Sciences Campus is perfectly positioned at the heart of a dynamic life sciences economic corridor. This corridor links Edmonton’s leading post-secondary institutions, innovation districts and industrial zones – creating the perfect conditions for breakthrough research, commercialization and manufacturing.
As the central hub of this corridor, the Life Sciences Campus plays a huge role in accelerating health and biotech activity across the province. At API, we see this as a transformative moment for Edmonton, but also for the rest of Canada, as it positions our country as a global leader in life sciences innovation.
Inside the Life Sciences Campus
Built to support the growth of companies across the pharmaceutical and biotechnology sectors, from early-stage startups to full-scale manufacturers, the Life Sciences Campus is split into two key zones: North and South. The North Campus is already a thriving ecosystem, home to flexible incubation spaces ranging from 500 to 10,000 sq. ft.
The North Campus is anchored by the Biotechnology Business Development Centre (BBDC), which serves as the nerve center for administration and innovation. With integrated warehousing and manufacturing capabilities, the BBDC is an ideal launchpad for emerging life sciences ventures ready to scale. Also, a part of the North Campus are several SMEs and Research Centre One (RC One) – a 41,000 square foot multi-tenant industrial building that accommodates a mix of office, production and wet lab spaces.
The South Campus offers ample room for future growth. Ideal for companies looking to build custom facilities from the ground up on undeveloped land, the South Campus expansion site is perfect for companies seeking proximity to North Campus resources without the need for intensive incubation support.
The centerpiece of the Life Sciences Campus – and a cornerstone of Canada’s biomanufacturing future – is the Critical Medicines Production Centre (CMPC). The CMPC is a joint-project led by API and the University of Alberta’s Li Ka Shing Institute, with the support of the Canadian Critical Drug Initiative (CCDI). Scheduled to be completed this coming year, the CMPC, which is over 83,000 square feet, is Canada’s largest facility dedicated to the security of supply for essential medicines. That means fewer disruptions in the availability of critical drugs, better emergency preparedness and a secure, domestic source of lifesaving treatments. Completion of the facility will also ensure foreign investors have a place to turn on the world’s stage for drug manufacturing. Alberta is quickly emerging as one of Canada’s fastest growing investment destinations, drawing record levels of venture capital across a range of sectors – including life sciences – as the province diversifies beyond oil and gas.
The CMPC will produce a range of essential medications while also assisting API in expanding our CDMO services as well. Essential medications will include sterile injectables, generic hospital-use drugs, anesthetics like Propofol and complex small-batch biologics. With the ability to rapidly respond to health crises and reduce dependency on international supply chains, the CMPC strengthens Canada’s pharmaceutical sovereignty and positions Canada as a global leader in pharmaceutical innovation.
Alberta is Where Change is Happening
Edmonton is uniquely equipped to support this type of advanced infrastructure. Home to multiple cGMP-certified facilities, the region offers a conducive environment for end-to-end drug development – including biologics, small molecules and cell therapies. With access to the petrochemical industry in Alberta’s Industrial Heartland, manufacturers’ benefits include access to cheap feedstocks, basic chemicals and chemical derivatives that are essential in the production of Active Pharmaceutical Ingredients (APIs.)
Beyond the technical advantages, Alberta’s business environment makes a strong case for companies looking to grow. With the lowest corporate tax rates in Canada and one of the most competitive tax climates in North America, Alberta offers significant cost advantages for scaling operations – especially in the capital-intensive pharmaceutical sector.
The Life Sciences Campus reflects a national imperative: to foster innovation and self-sufficiency in Canada’s healthcare system. Too often, Canadian research is commercialized abroad, meaning the value of homegrown science is realized elsewhere due to costs and funding opportunities. By investing in infrastructure like that of the Life Sciences Campus, API is reversing that trend – ensuring Canadian discoveries become Canadian solutions.
This commitment to Alberta and to Canada is grounded in a legacy of global impact. Canada led the world in the discovery of insulin, Canada drove HIV treatment innovations, and Canada helped develop lipid nanoparticles. Today, with the Life Sciences Campus and CMPC at the forefront, API is helping to continue that strong Canadian legacy in biomanufacturing, genomics, digital health and health AI.
At API, we believe the Life Sciences Campus is a national resource, driving collaboration, commercialization and Canadian-led innovation.
Cross-Sector Strengths That Power Life Sciences
The Life Sciences Campus also benefits from Alberta’s broader innovation landscape. The province’s leadership in clean technology, carbon capture and industrial processing supports biomanufacturing in both infrastructure and expertise. Edmonton’s status as a global AI hub, led by Amii, has created new opportunities in drug discovery, diagnostics and clinical trial optimization.
Meanwhile, the province’s AgTech and food innovation sectors provide natural synergies with cell agriculture, microbial production, and biotechnology. These industries don’t operate in isolation – they connect through shared talent pipelines, research collaborations and infrastructure. For companies at the Life Sciences Campus, this means more opportunities to grow, partner, and innovate.
Edmonton’s Invitation to Innovate
Edmonton is no longer a hidden gem – it’s a destination of choice for life sciences research, development, and biomanufacturing. With a collaborative and supportive innovation ecosystem, advanced infrastructure, and a growing global reputation, Alberta’s capital city is leading Canada’s next chapter in health innovation.
But the opportunity here goes beyond business. Edmonton offers a rare combination of affordability, quality of life, and access to talent. Whether you’re launching a startup or expanding global operations, the region provides an ideal environment to grow sustainably and competitively. From vibrant cultural experiences and top-tier education to short commutes and access to nature, Edmonton delivers the lifestyle and workforce that today’s innovators – and their teams – are looking for.
For investors and innovators, the opportunity is clear. The Life Sciences Campus is open for partnerships, investment, and expansion. With the Critical Medicines Production Centre set to transform Canada’s pharmaceutical capacity, now is the time to act.
Edmonton, and the Life Sciences Campus at Edmonton Research Park, is building the future of life sciences. The question is, will you be part of it?